Gaia
Gaia Health is developing controlled-release medication technologies designed to replace daily oral dosing with long-acting formulations that maintain steady therapeutic levels. The company integrates pharmaceutical science with consumer product design to reduce side effects and improve patient adherence for chronic disease management.
- Healthcare Technology
Funding
Founders
Founder details are not available yet.
Product
Problem
Nearly 50 percent of medication doses are not taken as prescribed, leading to poor patient outcomes and significant healthcare costs. Oral dosing causes unnecessary side effects as medicine passes through the stomach and liver, and daily dosing creates peaks and troughs that result in inconsistent therapeutic levels and poor disease management. Patients are frequently asked to reorganize their lives around their medication rather than having medicine designed to fit seamlessly into daily life.
Solution
Gaia Health is building the first pharmaceutical company to put patient experience at the center, replacing pills with controlled-release medications that put medicine on autopilot. The company combines cutting-edge science and drug development with world-class product design and technology leadership to create a future where medicine fades into the background. By developing advanced drug-delivery technologies, Gaia aims to create a new standard in good health, with medications designed to maintain steady therapeutic levels and reduce patient burden.
Target Audience
Primary customers are patients requiring chronic disease management who struggle with adherence to daily oral medication regimens, along with healthcare providers and payers seeking better therapeutic outcomes and reduced healthcare costs.
Features
- Controlled-release drug-delivery platform designed to replace conventional oral dosing
- Long-acting medication formulations intended to maintain consistent therapeutic levels without daily peaks and troughs
- Integration of pharmaceutical science with consumer product design principles to improve patient experience
- Approach aimed at reducing side effects by bypassing traditional gastrointestinal and hepatic metabolism pathways
- Technology infrastructure developed with leadership from major pharma companies including Genentech-Roche, Moderna, and Merck